18.05.2017Phenox as partner of WLNC - World Live Neurovascular Conference in Los Angeles
This Year, phenox again acts as a sponsor for the 5th WLNC – World Live Neurovascular Conference, one of the most important conferences in the field of stroke therapy. The congress, which was held from 15 until 18 May in Los Angeles, CA, US, addressing neuroradiologists, neurosurgeons and neurologists all over the world. One of the main topics
04.04.2017Congratulations - Our Dual Students made it!
With a festive ceremony the first two trainees of the dual curriculum finished their education as precision engineering technicians. Since 2015 the phenox GmbH offers the dual curriculum Physical Technology with fine mechanics as its core area (Bachelor of Science). This degree is made possible through the cooperation with GAEDIGK Feinmechanik & Systemtechnik GmbH, Westfälische Hochschule Gelsenkirchen and Handwerkskammer Dortmund. Lisa Gräbnitz and Peter Böker received their apprenticeship diploma on April 1st of 2017. The educational part at phenox GmbH is therefore done for our trainees.
03.11.2016phenox pREset Thrombectomy Device proves to be safe and effective
The treatment of mechanical thrombectomy represents a highly effective therapy in patients with acute ischemic stroke. This was recently proven by four randomized controlled trials (MR CLEAN1, SWIFT-PRIME2, EXTEND-IA3, ESCAPE4), in patients with a proximal large vessel occlusion. The ARTESp study, recently published by Dr. Sascha Prothmann, Department of Diagnostic and Interventional Neuroradiology at Klinikum rechts der Isar, et al., mirrors and reinforces the findings of the above mentioned trials.
07.03.2016SITS Open stroke trial includes pREset Thrombectomy Device by phenox GmbH
phenox GmbH, announces participation in the SITS Open clinical trial where pREset and pREset LITE Thrombectomy Devices have been included in the study device portfolio, one of only three devices to be used in the study.
Stroke is the second leading cause of death worldwide and the most common cause of adult disability in the western world. Ischemic stroke, caused by a blocked artery, is the most common type of stroke and it takes only minutes without oxygen for brain damage to occur and more brain cells die every minute that flow is blocked. The aim of physicians is to restore blood flow by opening the bloc
11.08.2015phenox project wins lead market competition
The project “FilaMem” is the winner of the lead market competition “NeueWerkstoffe.NRW” (New Materials North Rhine-Westphalia) and has therefore been nominated by the state government for a huge sponsorship combining state and EU funding. The development of biofunctional hybrid membranes for long-term implant materials is supposed to be realized in this project. In addition to phenox, the company femtos (located in Bochum as well), PS Materials (based in Aachen) and the medical faculty of RWTH Aachen University participate in the project’s implementation.
17.06.201510th anniversary of phenox
On the occasion of phenox’s 10th anniversary, a big celebration was held on June 12 on phenox’s premises. Around 150 employees and their family members attended the festivities which were accompanied by fine weather. Managing Partners Dr.-Ing. Hermann Monstadt and Ralf Hannes congratulated their colleagues who have been working with them for 10 years by presenting them with awards.
One week earlier, the Ruhr University Bochum (RUB) equally celebrated its anniversary which was called “BlauPause”: 2015 marks the 50th
16.10.2014phenox symposium at NeuroRAD 2014
As in recent years, the phenox GmbH is taking part in the annual meeting of the DGNR held from the 23rd to 25th October 2014 in Cologne. We cordially invite all participants to this year's symposium.
pREset LT - first experiences